Premarin conjugated estrogen tablets: Phase III data

Data from a 10.7-year follow-up of 7,645 evaluable postmenopausal women ages 50-79 with prior hysterectomy in the double-blind, U.S. Phase III Women's Health Initiative Estrogen-Alone trial showed tha...